THE COMPARISON OF PRINCIPLES OF ROCURONIUM DOSING IN PATIENTS WITH HIGH BODY-WEIGHT INDEX
https://doi.org/10.21292/2078-5658-2015-12-4-15-20
Abstract
The quality rates of neuromuscular block with various ways of dosing were compared for the patients with body weight index exceeding 40kg*m-2 who had laparoscopic surgery for gallstone disease. It has been found that dosing per actual body weight did not cause the danger of excessive duration and depths of neuromuscular block, the lowest doses were noted by dosing for ideal weight. The muscle relaxant dose did not define the development rate and the duration time of the block. The most close direct correlation has been found between the dose and area of body surface therefore the dosing of a muscle relaxant basing on calculation as per 23-33 mg/m2 is more preferable compared to traditional dosing per body weight in case of normal or high body weight index.
About the Authors
A. N. Shmakov
Novosibirsk State Medical University, Novosibirsk
Russian Federation
Russian Federation
N. L. Elizar'eva
Novosibirsk State Medical University, Novosibirsk
Russian Federation
Russian Federation
A. N. Kolosov
State Novosibirsk Regional Clinical Hospital, Novosibirsk
Russian Federation
Russian Federation
V. N. Kokhno
Novosibirsk State Medical University, Novosibirsk
Russian Federation
Russian Federation
L. B. Samoylova
State Novosibirsk Regional Clinical Hospital, Novosibirsk
Russian Federation
Russian Federation
References
1. Elizar'eva N.L., Kolosov А.N., Shmakov А.N. et al. The choice of criteria for rocuronium dosing in very obese patients. Meditsina i Obrazovanie v Sibiri no. 5, 2014, Available at гhttp://www.ngmu.ru/cozo/mos/article/text_full.php?id=1538
2. Tur A.F. Propedevtika detskikh bolezney. [Propedeutics of children diseases]. Moscow, Meditsina Publ., 1967, 792 p.
3. Fedotov E.A., Elizar'eva N.L., Shmakov A.N. et al. Course and reversion of neuromuscular block in obese patients. Meditsina i Obrazovanie v Sibiri, no. 4, 2013, Available at http://www.ngmu.ru/cozo/mos/article/text_full.php?id=1047
4. Fujimoto M., Tanahira C., Nishi M. et al. In non-obese patients, duration of action of rocuronium is directly correlated with body mass index. Published online: 6 March 2013, Canadian Anesthesiologists’ Society 2013
5. Leykin Y., Pellis T., Lucca M. et al. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesthesia & Analgesia, 2004, vol. 99, no. 4, pp. 1086-1089.
6. Meyhoff C.S., Lund J., Jenstrup M. et al. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight? Anesthesia & Analgesia: 2009, vol. 109, no. 3, pp. 787-792.
7. Pühringer F.K., Keller C., Kleinsasser A. et al. Pharmacokinetics of rocuronium bromide in obese female patients. Eur. J. Anaesthesiol., 1999, vol. 16, no. 8, pp. 507-510.
Review
For citations:
Shmakov A.N., Elizar'eva N.L., Kolosov A.N., Kokhno V.N., Samoylova L.B. THE COMPARISON OF PRINCIPLES OF ROCURONIUM DOSING IN PATIENTS WITH HIGH BODY-WEIGHT INDEX. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2015;12(4):15-20. (In Russ.) https://doi.org/10.21292/2078-5658-2015-12-4-15-20
Email this article 